Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ITK deficiency presenting as autoimmune lymphoproliferative syndrome. | J Allergy Clin Immunol | 2021 | 32628964 | PubTator, text mining | PubMed |
| Immune metabolism in PD-1 blockade-based cancer immunotherapy. | Int Immunol | 2021 | 32622347 | PubTator, text mining | PubMed |
| Peculiar protrusions along tanycyte processes face diverse neural and nonneural cell types in the hypothalamic parenchyma. | J Comp Neurol | 2021 | 32515035 | PubTator, text mining | PubMed |
| Combinatorial efficacy of entospletinib and chemotherapy in patient-derived xenograft models of infant acute lymphoblastic leukemia. | Haematologica | 2021 | 32414848 | PubTator, text mining | PubMed |
| Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations. | Mol Oncol | 2021 | 32191822 | PubTator, text mining | PubMed |
| Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer. | Explor Target Antitumor Ther | 2020 | 36046484 | PubTator, text mining | PubMed |
| Antitumor activity and safety of sirolimus for solid tumors with PIK3CA mutations: A multicenter, open-label, prospective single-arm study (KM 02-01, KCSG UN17-16). | Transl Cancer Res | 2020 | 35117688 | PubTator, text mining | PubMed |
| Concurrent presentation of brain arteriovenous malformation, peripheral arteriovenous malformation, and cerebellar astrocytoma: Case report. | Interdiscip Neurosurg | 2020 | 34307056 | PubTator, text mining | PubMed |
| Getting Sucker Punched by Depdc5 Really Hurts. | Epilepsy Curr | 2020 | 34025259 | PubTator, text mining | PubMed |
| MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways. | Front Oncol | 2020 | 33520717 | PubTator, text mining | PubMed |
| Multi-kinase targeted therapy as a promising treatment strategy for ovarian tumors expressing sfRon receptor. | Genes Cancer | 2020 | 33488949 | PubTator, text mining | PubMed |
| Selection of Effective Therapies Using Three-Dimensional in vitro Modeling of Chondrosarcoma. | Front Mol Biosci | 2020 | 33425984 | PubTator, text mining | PubMed |
| Sirolimus for the treatment of polyposis of the rectal remnant and ileal pouch in four patients with familial adenomatous polyposis: a pilot study. | BMJ Open Gastroenterol | 2020 | 33376109 | PubTator, text mining | PubMed |
| A quantitative analysis of the interplay of environment, neighborhood, and cell state in 3D spheroids. | Mol Syst Biol | 2020 | 33369114 | PubTator, text mining | PubMed |
| MicroRNA-1911-3p targets mEAK-7 to suppress mTOR signaling in human lung cancer cells. | Heliyon | 2020 | 33364499 | PubTator, text mining | PubMed |
| Quercetin Induces Apoptosis via Downregulation of Vascular Endothelial Growth Factor/Akt Signaling Pathway in Acute Myeloid Leukemia Cells. | Front Pharmacol | 2020 | 33362534 | PubTator, text mining | PubMed |
| T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice. | Sci Rep | 2020 | 33319815 | PubTator, text mining | PubMed |
| Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA. | Cell Death Dis | 2020 | 33311440 | PubTator, text mining | PubMed |
| mTOR Pathway in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NETs). | Front Endocrinol (Lausanne) | 2020 | 33304317 | PubTator, text mining | PubMed |
| Molecular subtyping of hepatocellular carcinoma: A step toward precision medicine. | Cancer Commun (Lond) | 2020 | 33290597 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=39